INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 168 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,102,576 | -16.1% | 1,110,081 | +8.2% | 0.01% | -7.7% |
| Q2 2023 | $41,851,166 | +36.9% | 1,026,241 | +25.1% | 0.01% | +30.0% |
| Q1 2023 | $30,578,172 | +95153.2% | 820,492 | -10.8% | 0.01% | +11.1% |
| Q4 2022 | $32,102 | -99.9% | 920,076 | +1.1% | 0.01% | -55.0% |
| Q3 2022 | $50,929,000 | +7.1% | 910,108 | -1.0% | 0.02% | +17.6% |
| Q2 2022 | $47,561,000 | -30.8% | 918,898 | -2.8% | 0.02% | -19.0% |
| Q1 2022 | $68,727,000 | -45.0% | 945,747 | -10.6% | 0.02% | -44.7% |
| Q4 2021 | $125,031,000 | -18.3% | 1,057,410 | -7.3% | 0.04% | -22.4% |
| Q3 2021 | $153,038,000 | -17.1% | 1,140,758 | +0.0% | 0.05% | -15.5% |
| Q2 2021 | $184,610,000 | +132.7% | 1,140,321 | +15.3% | 0.06% | +123.1% |
| Q1 2021 | $79,338,000 | +48.1% | 988,753 | +0.4% | 0.03% | +36.8% |
| Q4 2020 | $53,560,000 | +165.0% | 984,473 | -3.1% | 0.02% | +111.1% |
| Q3 2020 | $20,209,000 | -10.0% | 1,016,332 | -4.9% | 0.01% | -10.0% |
| Q2 2020 | $22,459,000 | +79.2% | 1,068,526 | +4.3% | 0.01% | +42.9% |
| Q1 2020 | $12,530,000 | -15.4% | 1,024,504 | +1.5% | 0.01% | +40.0% |
| Q4 2019 | $14,807,000 | +14.6% | 1,009,317 | +4.3% | 0.01% | 0.0% |
| Q3 2019 | $12,915,000 | -9.3% | 967,380 | +11.2% | 0.01% | -16.7% |
| Q2 2019 | $14,245,000 | +33.8% | 870,230 | +39.6% | 0.01% | +50.0% |
| Q1 2019 | $10,645,000 | +199.7% | 623,266 | +139.5% | 0.00% | +100.0% |
| Q4 2018 | $3,552,000 | +187.4% | 260,259 | +502.6% | 0.00% | – |
| Q3 2018 | $1,236,000 | +60.7% | 43,188 | +7.9% | 0.00% | – |
| Q4 2017 | $769,000 | -28.7% | 40,009 | -7.8% | 0.00% | – |
| Q3 2017 | $1,079,000 | +55.3% | 43,409 | 0.0% | 0.00% | – |
| Q2 2017 | $695,000 | – | 43,409 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |